Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.
Affiliation
PromPT Genito-Urinary Cancer Research, Cancer Research UK Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.Issue Date
2005-02-14
Metadata
Show full item recordAbstract
Prostate cancer has a predilection to metastasise to the bone marrow stroma (BMS) by an as yet uncharacterised mechanism. We have defined a series of coculture models of invasion, which simulate the blood/BMS boundary and allow the elucidation of the signalling and mechanics of trans-endothelial migration within the complex bone marrow environment. Confocal microscopy shows that prostate epithelial cells bind specifically to bone marrow endothelial-to-endothelial cell junctions and initiate endothelial cell retraction. Trans-endothelial migration proceeds via an epithelial cell pseudopodial process, with complete epithelial migration occurring after 232+/-43 min. Stromal-derived factor-1 (SDF-1)/CXCR4 signalling induced PC-3 to invade across a basement membrane although the level of invasion was 3.5-fold less than invasion towards BMS (P=0.0007) or bone marrow endothelial cells (P=0.004). Maximal SDF-1 signalling of invasion was completely inhibited by 10 microM of the SDF-1 inhibitor T140. However, 10 microM T140 only reduced invasion towards BMS and bone marrow endothelial cells by 59% (P=0.001) and 29% (P=0.011), respectively. This study highlights the need to examine the potential roles of signalling molecules and/or inhibitors, not just in single-cell models but in coculture models that mimic the complex environment of the bone marrow.Citation
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. 2005, 92 (3):503-12 Br. J. CancerJournal
British Journal of CancerDOI
10.1038/sj.bjc.6602325PubMed ID
15668715Type
ArticleLanguage
enISSN
0007-0920ae974a485f413a2113503eed53cd6c53
10.1038/sj.bjc.6602325
Scopus Count
Related articles
- Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion.
- Authors: Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH
- Issue date: 2001 May 18
- Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
- Authors: Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK
- Issue date: 2002 Mar 15
- Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma.
- Authors: Lang SH, Clarke NW, George NJ, Allen TD, Testa NG
- Issue date: 1998 Feb 15
- CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
- Authors: Gravina GL, Mancini A, Muzi P, Ventura L, Biordi L, Ricevuto E, Pompili S, Mattei C, Di Cesare E, Jannini EA, Festuccia C
- Issue date: 2015 Sep
- AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
- Authors: Zhu WB, Zhao ZF, Zhou X
- Issue date: 2019 Jul